NCT04118244

Brief Summary

Dynamic preload indices, such as pulse pressure variation (PPV) and stroke volume variation (SVV) are generally accepted as accurate indicator of fluid responsiveness in mechanically ventilated patients. Because SVV and PPV are generated by the pressure transmitted from the airways to the pleural and pericardial spaces, their reliability is limited in patients receiving low tidal volume (VT) ventilation and in those with a driving pressure lower than 20 cm H2O. Lung-protective ventilation using low VT with positive end expiratory pressure (PEEP) has recently been demonstrated to significantly improve postoperative outcome, and its application is gradually increasing in surgical patients. However, protective ventilation alters the predictability of dynamic preload indices and thus limits their use in the operating theatre. Lung recruitment maneuvers (LRMs), used to reopen collapsed lung, and PEEP have been proposed as the key components of lung-protective ventilation strategy. LRM increases intrathoracic pressure, which in turn causes a transient decrease in stroke volume (SV) and arterial pressure; this may depend on preload status. Interestingly, recent study reported that the augmented PPV during LRM using vital capacity maneuver (VCM, continuous positive airway pressure of 30 cm H2O for 10 s) could predict preload responsiveness under open chest condition. Investigators hypothesized that the augmented PPV and SVV by a stepwise LRM with incremental PEEP could represent a functional test to suggest preload responsiveness and, therefore, predict fluid responsiveness. The aims of the current study were (1) to assess the ability of augmented PPV and SVV during stepwise LRM-induced to predict fluid responsiveness in mechanically ventilated patients in the operating room, (2) to assess the ability of stepwise LRM-induced decrease in SV (ΔSV-LRM) to predict fluid responsiveness.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Oct 2019

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 2, 2019

Completed
5 days until next milestone

Study Start

First participant enrolled

October 7, 2019

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 8, 2019

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2021

Completed
Last Updated

January 29, 2026

Status Verified

January 1, 2026

Enrollment Period

2.1 years

First QC Date

October 2, 2019

Last Update Submit

January 28, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • PPV_augmented

    augmented pulse pressure variation by lung recruitment maneuver

    During the last 5 second of lung recruitment maneuver

  • SVV_augmented

    augmented stroke volume variation by lung recruitment maneuver

    During the last 5 second of lung recruitment maneuver

Secondary Outcomes (2)

  • ΔSV_LRM

    During the last 5 second of lung recruitment maneuver

  • ΔETCO2_LRM

    During the last 5 second of lung recruitment maneuver

Interventions

The ventilator was switched to pressure control ventilation, inspiratory time was increased to 50%, the peak inspiratory pressure gradient (above PEEP) was set at 15cm H2O, and PEEP was progressively increased to obtain a stepwise increase of peak inspiratory to 20, 25, and 30 cm H2O every three breaths. The final recruiting pressure of 30 cm H2O was applied for six breaths.

Eligibility Criteria

Age20 Years - 80 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

tertiary care center

You may qualify if:

  • Adult patients receiving laparotomy and lung protective ventilation

You may not qualify if:

  • preoperative arrhythmia
  • Severe bradycardia
  • Moderate to severe valvular disease
  • left ventricular ejection fraction \< 50%
  • Poorly controlled hypertension (systolic BP \> 160 mmHg)
  • Patients with renal insufficiency (creatinine \> 1.5 mg/dL)
  • Moderate to severe liver disease
  • BMI \>.30 or \< 15 kg/ m2
  • preexisting pulmonary disease
  • FEV1 \< 60% of predicted value

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kangnam Sacred Heart Hospital, Hallym University College of Medicine

Seoul, South Korea

Location

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

October 2, 2019

First Posted

October 8, 2019

Study Start

October 7, 2019

Primary Completion

October 31, 2021

Study Completion

October 31, 2021

Last Updated

January 29, 2026

Record last verified: 2026-01

Locations